Shopping Cart
- Remove All
- Your shopping cart is currently empty
SC 19220 is a prostaglandin E2 receptor EP1 antagonist.SC 19220 inhibits RANKL-induced osteoclastogenesis by inhibiting the RANK/RANKL signaling pathway in osteoclast precursors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $49 | In Stock | |
5 mg | $213 | In Stock | |
10 mg | $365 | In Stock | |
25 mg | $786 | In Stock |
Description | SC 19220 is a prostaglandin E2 receptor EP1 antagonist.SC 19220 inhibits RANKL-induced osteoclastogenesis by inhibiting the RANK/RANKL signaling pathway in osteoclast precursors. |
In vivo | SC 19220 (5-20 mg/kg, i.v.), a competitive PGE receptor antagonist, enhances bladder capacity and attenuates voiding efficiency when voiding is induced by slow intravesical filling in urethane-anesthetized rats. [1] |
Alias | SC19220 |
Molecular Weight | 331.75 |
Formula | C16H14ClN3O3 |
Cas No. | 19395-87-0 |
Smiles | O=C(NNC(=O)C)N1C2=CC(Cl)=CC=C2OC=3C=CC=CC3C1 |
Relative Density. | 1.38g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (241.15 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.